Initial experience of combination nivolumab and local-regional treatment in patients with advanced hepatocellular carcinoma (HCC).

e16149Background: HCC is the second-leading cause of cancer-related deaths in the world and has the fastest rising incidence and mortality in the U.S. The high mortality rate is due to the late sta...